RTI Surgical announced the full market launch of the Streamline OCT System.
The system is intended to promote fusion of the occipto-cervico-thoracic spine. It can be used in the treatment of spinal stenosis, tumors, degenerative disc disease and spondylolisthesis, among other conditions. It received 510(k) clearance from the U.S. Food and Drug Administration in March.
RTI Surgical is a global surgical implant company providing surgeons with safe biologic, metal and synthetic implants.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws